Suppr超能文献

辅助卵母细胞激活可显著提高受精失败史患者的受精卵形成、卵裂和着床率。

Assisted oocyte activation significantly improves zygote formation, cleavage, and implantation rates in patients with a history of fertilization failures.

机构信息

1IVF Department, Ob/Gyn "Dr. Shterev Hospital", Sofia, Bulgaria.

2Department of Obstetrics and Gynecology, Faculty of Medicine, Medical University Sofia, Sofia, Bulgaria.

出版信息

Physiol Int. 2024 Aug 16;111(3):207-221. doi: 10.1556/2060.2024.00342. Print 2024 Sep 18.

Abstract

BACKGROUND

Fertilization check performed at the 18th hour following classic in vitro fertilization procedure (IVF) or intracytoplasmic sperm injection (ICSI) is a critical stage in assisted reproduction. The success of the treatment is significantly reliant on the quantity of zygotes exhibiting two pronuclei. Consequently, low fertilization rates or complete fertilization failure are highly undesirable outcomes for both patients and reproductive specialists. Applying additional calcium ionophore for oocyte activation subsequent to ICSI may offer benefits and potentially enhance treatment outcomes, particularly for patients who have experienced low or absent fertilization rates (FR) in previous treatment cycles. The aim of the study is to evaluate the efficacy of Ca2+ ionophore application for oocyte activation.

METHODS

A retrospective analysis of 924 oocytes obtained from 120 patients who underwent ICSI cycles with a history of low or no fertilization as a result of previous unsuccessful treatment rounds. The next ART cycle followed with additional oocyte Ca2+ ionophore activation applied in 57 of the cases in order to optimize the treatment process (Group 1), and 63 patients were included and their outcomes followed as a control group (Group 2).We conducted a comparative analysis of results in both groups. The study's primary outcomes encompassed fertilization, cleavage embryo quality, blastocyst rate, and established clinical pregnancies.

RESULTS

At day 1 fertilization check we had 274/386 zygotes (71%FR) in group 1 and 132/410 in group 2 (32.2%FR), (P < 0.0001). Twenty-two (34.9%) cycles in group 2 resulted in total fertilization failure (TFF). At the cleavage stage top-quality embryos from group 1 were significantly higher (P = 0.0021) in comparison to group 2. Forty-eight embryo transfers (ET) were performed in group 1 resulting in 41.67% clinical pregnancies versus 33 ET and only 4 pregnancies (12.12%) for group 2 (P = 0.0044).

CONCLUSIONS

The results confirm the appropriateness of assisted oocyte activation as an additional method in cases of previous fertilization failure cycles.

摘要

背景

在经典体外受精(IVF)或胞浆内单精子注射(ICSI)程序后 18 小时进行受精检查是辅助生殖的关键阶段。治疗的成功与否在很大程度上取决于具有两个原核的受精卵数量。因此,对于患者和生殖专家来说,低受精率或完全受精失败都是极不理想的结果。在 ICSI 后应用额外的钙离子载体激活卵子可能会带来益处,并有可能改善治疗结果,特别是对于在前几个治疗周期中经历过低受精率(FR)或无受精的患者。本研究的目的是评估钙离子载体在卵母细胞激活中的应用效果。

方法

对 120 例因前次治疗周期失败而导致低受精或无受精史的患者的 924 个卵母细胞进行回顾性分析。在下一次的辅助生殖技术(ART)周期中,其中 57 例应用额外的卵母细胞钙离子载体激活以优化治疗过程(第 1 组),并对 63 例患者进行了随访作为对照组(第 2 组)。我们对两组的结果进行了比较分析。研究的主要结果包括受精、卵裂胚胎质量、囊胚率和已建立的临床妊娠。

结果

在第 1 天的受精检查中,第 1 组有 274/386 个受精卵(71%的 FR),第 2 组有 132/410 个受精卵(32.2%的 FR),差异有统计学意义(P < 0.0001)。第 2 组有 22 个(34.9%)周期出现完全受精失败(TFF)。在卵裂阶段,第 1 组的优质胚胎数量明显高于第 2 组(P = 0.0021)。第 1 组进行了 48 次胚胎移植(ET),临床妊娠率为 41.67%,而第 2 组进行了 33 次 ET,仅获得 4 例妊娠(12.12%),差异有统计学意义(P = 0.0044)。

结论

这些结果证实了辅助卵母细胞激活作为既往受精失败周期的一种额外方法的适宜性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验